Skip to main content

Confronting antimicrobial resistance together.

Publication ,  Journal Article
Chambers, HF; Fowler, VG; Antibacterial Resistance Leadership Group,
Published in: Am J Physiol Lung Cell Mol Physiol
November 1, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Physiol Lung Cell Mol Physiol

DOI

EISSN

1522-1504

Publication Date

November 1, 2022

Volume

323

Issue

5

Start / End Page

L643 / L645

Location

United States

Related Subject Headings

  • Respiratory System
  • Pulmonary Disease, Chronic Obstructive
  • Premature Birth
  • Pneumonia
  • Infant, Newborn
  • Humans
  • Global Health
  • Female
  • Drug Resistance, Bacterial
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chambers, H. F., Fowler, V. G., & Antibacterial Resistance Leadership Group, . (2022). Confronting antimicrobial resistance together. Am J Physiol Lung Cell Mol Physiol, 323(5), L643–L645. https://doi.org/10.1152/ajplung.00327.2022
Chambers, Henry F., Vance G. Fowler, and Vance G. Antibacterial Resistance Leadership Group. “Confronting antimicrobial resistance together.Am J Physiol Lung Cell Mol Physiol 323, no. 5 (November 1, 2022): L643–45. https://doi.org/10.1152/ajplung.00327.2022.
Chambers HF, Fowler VG, Antibacterial Resistance Leadership Group. Confronting antimicrobial resistance together. Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L643–5.
Chambers, Henry F., et al. “Confronting antimicrobial resistance together.Am J Physiol Lung Cell Mol Physiol, vol. 323, no. 5, Nov. 2022, pp. L643–45. Pubmed, doi:10.1152/ajplung.00327.2022.
Chambers HF, Fowler VG, Antibacterial Resistance Leadership Group. Confronting antimicrobial resistance together. Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L643–L645.

Published In

Am J Physiol Lung Cell Mol Physiol

DOI

EISSN

1522-1504

Publication Date

November 1, 2022

Volume

323

Issue

5

Start / End Page

L643 / L645

Location

United States

Related Subject Headings

  • Respiratory System
  • Pulmonary Disease, Chronic Obstructive
  • Premature Birth
  • Pneumonia
  • Infant, Newborn
  • Humans
  • Global Health
  • Female
  • Drug Resistance, Bacterial
  • Anti-Bacterial Agents